Hyponatremia Treatment
Treatment of hyponatremia must be guided by symptom severity and chronicity, with severely symptomatic patients requiring immediate hypertonic saline to prevent cerebral edema and death, while chronic asymptomatic cases demand cautious correction to avoid osmotic demyelination syndrome.
Acute Severely Symptomatic Hyponatremia
For patients with severe symptoms (altered mental status, seizures, coma), immediately administer 3% hypertonic saline as a 100-150 mL IV bolus 1, 2. The goal is to correct 6 mmol/L over 6 hours or until severe symptoms resolve 1.
Critical Correction Limits
- Maximum correction: 8 mmol/L in first 24 hours 1
- If you correct 6 mmol/L in the first 6 hours, limit additional correction to only 2 mmol/L over the remaining 18 hours 1
- Monitor sodium every 2 hours in ICU setting 1
Calculation
Use the sodium deficit formula: Desired increase in Na (mEq) × (0.5 × ideal body weight in kg) 1
Common Pitfall: The retrospective data showing mortality benefit with faster correction in patients with Na <115 mmol/L 1 must be balanced against the risk of osmotic demyelination. The guideline limits remain appropriate as overcorrection occurred in 2.3% even with targeted protocols 3.
Chronic or Mildly Symptomatic Hyponatremia
Chronic hyponatremia should NOT be rapidly corrected 1. Rapid correction >1 mmol/L/hour risks osmotic demyelination syndrome, which can cause permanent neurological damage including parkinsonism and quadriparesis 2.
Treatment Algorithm by Etiology
SIADH (Syndrome of Inappropriate Antidiuretic Hormone):
- First-line: Fluid restriction to 1 L/day 1, 2
- Monitor sodium every 4 hours initially, then daily 1
- Add adequate solute intake (salt and protein) 4
If fluid restriction fails (occurs in ~50% of SIADH patients) 4:
- Second-line options:
Cerebral Salt Wasting (CSW):
- Hypertonic saline PLUS fludrocortisone for 7 days 1
- Add normal saline IVF if inadequate response 1
- Target sodium of 131 mmol/L (exception: SAH patients treated even at 131-135 mmol/L) 1
Asymptomatic Hyponatremia
For mild asymptomatic hyponatremia, start with adequate solute intake (salt and protein) plus initial fluid restriction of 500 mL/day, adjusted based on sodium levels 4.
When to Consider Vaptans
Vaptans may be considered in euvolemic or hypervolemic patients with documented high ADH activity 4. However, there is presently no role for vaptans in acute symptomatic hyponatremia 5. The cost of tolvaptan makes routine use prohibitive for most asymptomatic patients 5.
Volume Status Matters
Treatment differs by volume status 1:
- Hypovolemic: Rule out extrarenal losses, diuretics, adrenal insufficiency
- Euvolemic: Rule out thyroid disease, hypocortisolism before diagnosing SIADH
- Hypervolemic: Consider heart failure, cirrhosis, renal failure
Monitoring Requirements
Severe symptoms:
Mild symptoms:
Evidence Strength Considerations
The 2009 neurosurgical guidelines 1 provide the most algorithmic approach, though focused on neurosurgical populations. More recent data from 2024 4 and 2022 2 support similar principles but emphasize that a 2026 randomized trial found targeted correction did not reduce 30-day mortality or rehospitalization compared to routine care 3. This suggests hyponatremia may be more of a disease severity marker than a direct cause of mortality in chronic cases. However, this does NOT change the approach to acute symptomatic hyponatremia, which remains a medical emergency requiring immediate treatment 2, 6.
The consensus from 20 medical centers across 9 countries strongly recommends maintaining current cautious correction limits rather than abandoning safeguards 6.